NAGENDRAN SUKUMAR sold 17.6% of their position (200K shares) of TAYSHA GENE THERAPIES, INC. on the open market
Open‑market sale worth $1.25M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/10/2026ACC: 0001665124-26-000013
Director
Since Sep 2020
-200K
Net shares
Net seller
$1.25M
Total sold
1
Open market trades
0B · 1S
1
Total transactions
200K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−200K
Price / share
$6.24
Trade value
$1.25M
% of position
17.6%
7/10/2026
1.14M→936.41K
Total
Net shares
−200K
Net value
-$1.25M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/10/2026 | S · Sale | −200K | $6.24 | $1.25M | 17.6% | 1.14M | 936.41K |
| Total | −200K | -$1.25M | ||||||
Derivative Transactions0
No derivative transactions reported